Elsevier launches Malaria Nexus resource to benefit malaria researchers worldwide

Elsevier, the world-leading publisher of scientific, technical and medical information products and services, today announced the launch of Malaria Nexus, Elsevier's Global Malaria Resource, www.malarianexus.com.

Malaria Nexus highlights the latest published research in Malaria, utilizing Elsevier's leading journals in Parasitology, Entomology and Tropical Medicine, including The Lancet-, The Lancet Infectious Diseases, Transactions of the Royal Society of Tropical Medicine and Hygiene, and International Journal for Parasitology.

"The aim of Malaria Nexus is to be a comprehensive resource and hub of knowledge for malaria researchers worldwide" said Dale Seaton, Executive Publisher for Parasitology, at Elsevier. "As well as making our latest malaria publications free to download, we want to go beyond the article, and become a leading forum for discussion between researchers, editors and opinion leaders."

The site features interviews with key authors, who can expand on their highlighted published work, as well as editors of some of Elsevier's most prestigious journal titles. Active participation and feedback from interested parties is encouraged. Currently featuring article feeds from 13 journals, the site will include additional relevant journals over the coming months.

John Beier, Editor of the participating journal Acta Tropica, said, "From remote settings in malaria endemic areas to sophisticated laboratories, malaria researchers from around the world will certainly benefit from using Malaria Nexus by reading timely highlights of first class publications, learning the views of leading malaria experts, and expressing their important opinions in this new forum for exchange of information."

Source: Elsevier

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New drug MED6-189 shows promise against drug-resistant malaria